Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...

A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, we found that the claim is false.

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S. officials stockpiled 4.8 million doses of the vaccine that officials said was ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

Moderna beat on fourth-quarter revenue but lost ... That includes $193 million in write-downs of unused doses of the Covid vaccine, among other costs. Research and development expenses dropped ...

Explore the truth behind false claims that Moderna's CEO confessed to creating a COVID-19 vaccine before the pandemic, and the context of his remarks on vaccine production.